Related Experiment Video
Updated: Jun 16, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus
Gissette Reyes-Soffer1, Steve Holleran, Marco R Di Tullio
1Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA.
Insights
Individuals with coronary artery disease and type 2 diabetes mellitus experience greater endothelial dysfunction than those with only coronary artery disease. This finding highlights the impact of diabetes on vascular health in heart disease patients.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Vascular Biology
Background:
- Coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) are major global health concerns.
- Endothelial dysfunction (ED) is an early marker of cardiovascular disease.
- The combined impact of CAD and T2DM on ED requires further elucidation.
Purpose of the Study:
- To investigate whether individuals with both CAD and T2DM exhibit greater endothelial dysfunction compared to individuals with CAD alone.
- To assess the independent association of T2DM with ED in patients with established CAD.
Main Methods:
- Flow-mediated dilation (FMD) was measured in two cohorts of patients with CAD.
- FMD, a measure of endothelial function, was assessed via percentage increase in brachial artery diameter.
- Statistical analysis, including multiple regression, adjusted for covariates like age and body mass index.
Main Results:
- A cohort of 103 patients with CAD (52 T2DM+, 51 T2DM-) was analyzed.
- Patients with both CAD and T2DM (T2DM+) showed significantly lower mean FMD (3.9%) compared to those with CAD only (T2DM-, 5.5%; P < .03).
- Adjusting for age and BMI, T2DM remained independently associated with greater ED (difference, -1.99%; P < .03).
Conclusions:
- Concomitant T2DM in patients with CAD is independently linked to increased endothelial dysfunction.
- This heightened ED may contribute to the elevated morbidity and mortality observed in patients with both conditions.
- Findings underscore the critical need for managing T2DM in CAD patients to mitigate vascular complications.
Abstract:
The goal of this study was to determine if individuals with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) had greater endothelial dysfunction (ED) than individuals with only CAD. Flow-mediated dilation (FMD), calculated as percentage increase in brachial artery diameter in response to postischemic blood flow, was measured after an overnight fast in 2 cohorts. The first cohort included 76 participants in the Northern Manhattan Study with CAD; 25 also had T2DM. The second cohort was composed of 27 individuals with both T2DM and CAD who were participants in a study of postprandial lipemia. Combined, we analyzed 103 patients with CAD: 52 with T2DM (T2DM+) and 51 without T2DM (T2DM-). The 52 CAD T2DM+ subjects had a mean FMD of 3.9% +/- 3.2%, whereas the 51 CAD T2DM- subjects had a greater mean FMD of 5.5% +/- 4.0% (P < .03). An investigation of various confounders known to affect FMD identified age and body mass index as the only significant covariates in a multiple regression model. Adjusting for age and body mass index, we found that FMD remained lower in T2DM+ subjects compared with T2DM- subjects (difference, -1.99%; P < .03). In patients with CAD, the concomitant presence of T2DM is independently associated with greater ED, as measured by FMD. This finding may be relevant to the greater early and late morbidity and mortality observed in patients with both CAD and T2DM.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease I: Introduction